Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-90.19%Buyback Yield
VS
Market
Sector
Industry
History
$ 0.47Close
$ 0.27 - $ 3.09 52-Week Range
Ticker Information
Ticker
MBRXCompany Name
MOLECULIN BIOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMOLECULIN BIOTECH INC - Buyback Yield Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MBRX - Buyback Yield Historical data
| Date | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
|---|---|---|---|
| 6/30/2025 | -90.19% | $ 20.05M | $ 18.08M |
| 3/31/2025 | -83.75% | $ 15.12M | $ 12.66M |
| 12/31/2024 | -30.54% | $ 15.26M | $ 4.66M |
| 9/30/2024 | -112.54% | $ 7.65M | $ 8.62M |
| 6/30/2024 | -65.7% | $ 6.02M | $ 3.96M |
| 3/31/2024 | -36.58% | $ 11M | $ 4.03M |
| 12/31/2023 | -32.78% | $ 12.71M | $ 4.17M |
| 9/30/2023 | -1.23% | $ 17.18M | $ 211K |
| 6/30/2023 | -1.12% | $ 18.78M | $ 211K |
| 3/31/2023 | -0.61% | $ 23.15M | $ 141K |
Key Performance Insights, Last 5 Years
- MOLECULIN BIOTECH INC's latest trailing twelve months (TTM) Buyback Yield stands at -38.52%.
- Over the past 5 years, MOLECULIN BIOTECH INC's average Buyback Yield has been -48.03%.
- The median Buyback Yield for MOLECULIN BIOTECH INC during this period was -34.68%
- MOLECULIN BIOTECH INC reached its highest Buyback Yield over the past 5 years at 0%.
- The lowest Buyback Yield recorded by MOLECULIN BIOTECH INC in the same timeframe -145.31%
Similar metrics to CF - Equity:
- Payout Yield - [Calculation] The Payout Yield describes the percentage a business is returning to its shareholders in the form of share buybacks and dividends.
- Shareholder Yield - [Calculation] The Shareholder Yield is a ratio that indicates how much money the business is giving back to shareholders. A business can return to shareholders through dividends [DivYield], share repurchases [BuybackYield], and debt reduction [DebtPaydownYield].
- Debt Paydown Yield - [Calculation] The Debt Paydown Yield measures the net change in longterm [Debt] divided by the company’s [MarketCap]. A high debt pay down yield indicates that the business is aggressively paying down debt which increases shareholder [Equity].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Net Cash Flow - Issuance (Purchase) of Equity Shares - [Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).
Definition of Buyback Yield
[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.(-1 * CF - Equity) / Market Cap
(=) Buyback Yield Buyback Yield for MOLECULIN BIOTECH INC is calculated as follows: (-1 * CF - Equity [ $ 17.08M ]) / Market Cap [ $ 44.35M ]
(=) Buyback Yield [ -38.52% ] MBRX - Buyback Yield, Last 5 years
-145.31%
Minimum
Dec 31, 2021
0%
Maximum
Sep 30, 2022
-48.03%
Average
-34.68%
Median
Buyback Yield Benchmark AnalysisMarket
The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.71%.
The following table provides additional summary stats:
Buyback Yield in the Market:
| filtered constituents | 3.28K |
|---|---|
| min | -8.43% |
| max | 8.43% |
| average | 0.64% |
| median | 0.01% |
| std | 2.71% |